Cite

HARVARD Citation

    Lin, H. et al. (n.d.). Gender and BCR‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia. European journal of haematology. pp. 360-366. [Online]. 
  
Back to record